alpha-cyano-4-hydroxycinnamate has been researched along with Diabetes Mellitus, Type 1 in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, FJ | 1 |
| Chen, SY | 1 |
| Liu, YC | 1 |
| Liao, HY | 1 |
| Chen, CJ | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice.
Topics: Acetonitriles; Aflatoxin B1; Animals; Chromatography, Liquid; Coumaric Acids; Diabetes Mellitus, Typ | 2017 |